Results 271 to 280 of about 447,569 (400)
Posterior Reversible Encephalopathy Syndrome (PRES) Following Fruquintinib in a Normotensive Patient With Metastatic Colorectal Cancer: A Case Report. [PDF]
ElManfalouty R +3 more
europepmc +1 more source
Stiripentol use in Dravet syndrome patients in the USA: Results of a real‐world study
Abstract Objective Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy with a high seizure burden and mortality risk. Stiripentol, one of the first DS‐specific therapies, received FDA approval in 2018 but its real‐world use and impact post‐approval in the USA remain insufficiently characterized.
Elaine Wirrell +11 more
wiley +1 more source
Hashimoto's Encephalopathy-Induced Personality Changes: A Rare Case Report. [PDF]
Vijayan S +3 more
europepmc +1 more source
Abstract Objective Variants in KCNQ2 encoding the voltage‐gated potassium channel KV7.2 are associated with developmental and epileptic encephalopathy (DEE) of varying severity. This study examined the relationship of KCNQ2 variant dysfunction with the neurodevelopmental phenotype of individuals with KCNQ2‐DEE. Methods A parent‐reported survey gathered
Jessa S. Bidwell +4 more
wiley +1 more source
When Autoimmunity and Vascular Events Collide: A Unique Presentation of Hashimoto's Encephalopathy and Ischemic Stroke. [PDF]
Cornejo Leon MC, Noorbakhsh-Sabet N.
europepmc +1 more source
Abstract Objectives Infantile epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy of infantile onset. While epidemiological data from Western countries and global estimates are available, consolidated evidence on the burden of IESS in India remains limited.
Akanksha Singh +6 more
wiley +1 more source
Abstract Objective Dravet syndrome (DS) is a rare disease with a high clinical and socioeconomic impact on patients, society, and the healthcare system. The recent approval of therapies such as fenfluramine (FFA) has transformed the treatment landscape; however, data on their cost‐effectiveness are still scarce. This study evaluates the real‐world cost‐
Paolo A. Cortesi +15 more
wiley +1 more source

